I. Jialal

发表

I. Jialal, C. Scaccini, 1992 .

Increased Toll-like Receptor (tlr) 2 and Tlr4 Expression in Monocytes from Patients with Type 1 Diabetes: Further

S. Griffen, S. Devaraj, I. Jialal, 2022 .

Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.

S. Grundy, S. Devaraj, I. Jialal, 2000, Atherosclerosis.

The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease.

S. Devaraj, I. Jialal, 2006, Nutrition reviews.

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?

Sridevi Devaraj, S. Devaraj, I. Jialal, 2010, Current atherosclerosis reports.

Anti‐inflammatory Strategies to Prevent Diabetic Cardiovascular Disease

S. Devaraj, I. Jialal, 2015, Clinical pharmacology and therapeutics.

Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus

I. Jialal, S. Dhindsa, 2014, Current Diabetes Reports.

Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.

M. Bajaj, I. Jialal, 2009, Metabolic syndrome and related disorders.

Oxidative stress, alpha-tocopherol therapy, and atherosclerosis

S. Devaraj, I. Jialal, A. Harris, 2002, Current atherosclerosis reports.

α-Tocopherol and Atherosclerosis

S. Devaraj, I. Jialal, N. Kaul, 2001 .

Antioxidants and vitamins to reduce cardiovascular disease

S. Devaraj, I. Jialal, 2000, Current atherosclerosis reports.

Epigenetic regulation of high glucose‐induced proinflammatory cytokine production in monocytes by curcumin

S. Devaraj, I. Jialal, Jung-Mi Yun, 2010, The Journal of nutritional biochemistry.

C-Reactive Protein Polarizes Human Macrophages to an M1 Phenotype and Inhibits Transformation to the M2 Phenotype

S. Devaraj, I. Jialal, 2011, Arteriosclerosis, thrombosis, and vascular biology.

C-Reactive Protein Polarizes Human Macrophages to an M 1 Phenotype and Inhibits Transformation to the M 2 Phenotype

S. Devaraj, I. Jialal, 2011 .

Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease

S. Devaraj, I. Jialal, Surekha Mathur, 2002, Current opinion in nephrology and hypertension.

Exploratory metabolomics of metabolic syndrome: A status report

I. Jialal, Daniella Lent-Schochet, M. McLaughlin, 2019, World journal of diabetes.

Selective increase in monocyte p38 mitogen-activated protein kinase activity in metabolic syndrome

B. Adams-Huet, I. Jialal, R. Pahwa, 2016, Diabetes & vascular disease research.

Targeting inflammation to reduce ASCVD in type 2 diabetes.

A. Chaudhuri, I. Jialal, 2019, Journal of diabetes and its complications.

Inflammation and atherosclerosis: fulfilling Koch’s postulates

I. Jialal, N. Vikram, 2018, Therapeutic advances in cardiovascular disease.

Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress.

R. Hammer, S. Grundy, E. Friedberg, 2001, Cancer research.

Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease

B. Adams-Huet, S. Devaraj, I. Jialal, 2007 .

Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.

J. D. de Lemos, B. Adams-Huet, S. Devaraj, 2007, The American journal of clinical nutrition.

Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers.

S. Grundy, I. Jialal, L. Cristol, 1992, Atherosclerosis.

Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay

S. Devaraj, I. Jialal, D. Siegel, 2017, Laboratory medicine.

Scientific evidence to support a vitamin E and heart disease health claim: research needs.

S. Devaraj, I. Jialal, 2005, The Journal of nutrition.

Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation).

S. Devaraj, I. Jialal, S. Hirany, 1995, American journal of clinical pathology.

Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues.

C. Kahn, S. Buzney, G. King, 1985, Endocrinology.

Somatomedin activity in diabetic patients.

I. Jialal, 1984, Clinical endocrinology.

Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus.

S. Devaraj, I. Jialal, R. M. Hsu, 2002, Clinica chimica acta; international journal of clinical chemistry.

Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario.

I. Jialal, C. Fuller, 1996, Critical reviews in food science and nutrition.

Oxidized LDL and antioxidants

I. Jialal, C. Fuller, 1993, Clinical cardiology.

Comparison of two assays for measuring LDL cholesterol.

A. Maitra, I. Jialal, S. Hirany, 1997, Clinical chemistry.

α-Tocopherol Decreases Interleukin-1β Release From Activated Human Monocytes by Inhibition of 5-Lipoxygenase

S. Devaraj, I. Jialal, 1999 .

Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase.

S. Devaraj, I. Jialal, 1999, Arteriosclerosis, thrombosis, and vascular biology.

α-Tocopherol Decreases Superoxide Anion Release in Human Monocytes Under Hyperglycemic Conditions Via Inhibition of Protein Kinase C-α

S. Devaraj, I. Jialal, T. Yang, 2002 .

Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.

S. Devaraj, I. Jialal, T. Yang, 2002, Diabetes.

Gastroenteropancreatic neuroendocrine tumors

I. Jialal, N. Ramakrishnan, Seong Ahn, 2021, Handbook of Diagnostic Endocrinology.

Dose-Response Comparison of RRR-α-Tocopherol and All-Racemic α-Tocopherol on LDL Oxidation

B. Adams-Huet, S. Devaraj, I. Jialal, 1997 .

Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective.

S. Devaraj, I. Jialal, 1996, Clinical chemistry.

Oxidized low-density lipoprotein and atherosclerosis

S. Devaraj, I. Jialal, 1996, International journal of clinical & laboratory research.

C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction.

S. Devaraj, I. Jialal, P. Kumaresan, 2011, Clinical chemistry.

Clinical utility of lactate dehydrogenase: a historical perspective.

L. Sokoll, I. Jialal, 2015, American journal of clinical pathology.

Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein.

S. Grundy, I. Jialal, S. M. Grundy, 1992, Journal of lipid research.

Oxidative Stress and Antioxidants in Type 2 Diabetes

I. Jialal, S. Devaraj, 2001 .

The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2018, Journal of diabetes and its complications.

The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.

B. Adams-Huet, I. Jialal, R. Pahwa, 2017, Journal of diabetes and its complications.

Effects of antioxidants and fatty acids on low-density-lipoprotein oxidation.

I. Jialal, C. Fuller, 1994, The American journal of clinical nutrition.

Vitamins E and C are safe across a broad range of intakes.

K. Kraemer, L. Packer, C. Johnston, 2005, The American journal of clinical nutrition.

The Adrenal Cortex

I. Jialal, W. Winter, R. Bertholf, 2012 .

Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay.

I. Jialal, R. Pahwa, A. Rosenberg, 2016, Clinical biochemistry.

Novel cholesteryl ester transfer protein inhibitors: promising therapy for dyslipidemia?

S. Devaraj, I. Jialal, 2011, Metabolic syndrome and related disorders.

Statin therapy in acute cardiovascular syndromes.

S. Devaraj, I. Jialal, 2007, Current opinion in lipidology.

Effect of Statin Therapy on Remnant Lipoprotein Cholesterol Levels in Patients With Combined Hyperlipidemia

B. Adams-Huet, S. Devaraj, I. Jialal, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Alpha-lipoic acid supplementation and diabetes.

U. Singh, I. Jialal, 2008, Nutrition reviews.

Laboratory Investigation of Dyslipidemia

I. Jialal, S.Allwin Devara, 1998 .

Plant Sterol-Fortified Orange Juice Effectively Lowers Cholesterol Levels in Mildly Hypercholesterolemic Healthy Individuals

S. Vega-López, S. Devaraj, I. Jialal, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans.

S. Grundy, S. Devaraj, I. Jialal, 2002, The Journal of nutrition.

Oral Pharmacotherapy as Alternative Treatment for Type 2 Diabetes Mellitus in a 61 Year Old Ethnic Filipino Man with Insulin Allergies.

I. Jialal, Richa Singh, 2018, Laboratory medicine.

Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.

S. Devaraj, I. Jialal, H. Kaur, 2014, The Journal of clinical endocrinology and metabolism.

Use of HbA1c in the diagnosis of diabetes and prediabetes: sensitivity versus specificity.

I. Jialal, N. Vikram, 2014, Metabolic syndrome and related disorders.

Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden.

I. Jialal, P. Reddy, Joseph Leong, 2018, Journal of diabetes and its complications.

Increased expression of Fc-γ receptors on monocytes in patients with nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2013, The Journal of clinical endocrinology and metabolism.

Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.

S. Grundy, E. Norkus, I. Jialal, 1996, Atherosclerosis.

β-Carotene inhibits the oxidative modification of low-density lipoprotein

S. Grundy, E. Norkus, I. Jialal, 1991 .

Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.

S. Grundy, I. Jialal, 1993, Circulation.

The effects of alpha-tocopherol on critical cells in atherogenesis.

S. Devaraj, I. Jialal, 1998, Current opinion in lipidology.

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome

S. Devaraj, I. Jialal, 2011, Experimental diabetes research.

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.

U. Singh, S. Devaraj, I. Jialal, 2010, Atherosclerosis.

Bile acid sequestrants and diabetes: introduction and overview to the supplement.

I. Jialal, 2010, Metabolic syndrome and related disorders.

Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.

I. Jialal, Stacey L. Abby, S. Nagendran, 2009, Metabolic syndrome and related disorders.

Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis.

J. Cigarroa, L. Hillis, R. Lange, 2004, Archives of pathology & laboratory medicine.

Effect of orange juice and beverage with phytosterols on cytokines and PAI-1 activity.

S. Devaraj, I. Jialal, Jason Rockwood, 2011, Clinical nutrition.

Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease.

S. Devaraj, I. Jialal, D. O’Byrne, 2000, Clinical chemistry.

Optimum lipid testing for diabetic patients to enhance clinical care.

S. Devaraj, I. Jialal, 2021, Diabetes & metabolic syndrome.

Management of diabetic dyslipidemia: Navigating the new American and European Guidelines.

I. Jialal, 2020, Diabetes & metabolic syndrome.

Management of Hypertriglyceridemia in the Diabetic Patient

I. Jialal, M. Kaur, William Amess, 2010, Current diabetes reports.

High glucose induces IL-1beta expression in human monocytes: mechanistic insights.

S. Devaraj, I. Jialal, M. Dasu, 2007, American journal of physiology. Endocrinology and metabolism.

Circulating versus cellular biomarkers of inflammation in Type 1 diabetes: the superiority of C-reactive protein.

S. Devaraj, I. Jialal, 2012, Cytokine.

Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.

S. Grundy, I. Jialal, Ishwarial Jialal, 1991, The Journal of clinical investigation.

Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.

A. Chait, I. Jialal, 1989, Journal of lipid research.

C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction.

Jose J. Galvez, S. Devaraj, I. Jialal, 2009, Cardiovascular research.

Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications.

S. Devaraj, I. Jialal, Jung-Mi Yun, 2011, American journal of clinical pathology.

Exploratory lipidomics in patients with nascent Metabolic Syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2018, Journal of diabetes and its complications.

C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase.

S. Devaraj, I. Jialal, M. Dasu, 2010, Clinical chemistry.

Fat of the matter: inflammation, the waist and cardiovascular risk

S. Devaraj, I. Jialal, 2009 .

EFFECTS OF LIFEPAK ® SUPPLEMENTATION ON ANTIOXIDANT STATUS AND LDL- OXIDATION IN HEALTHY NON-SMOKERS

S. Devaraj, I. Jialal, C. Smidt, 2004 .

C-reactive protein and the vascular endothelium: implications for plaque instability.

U. Singh, S. Devaraj, I. Jialal, 2006, Journal of the American College of Cardiology.

Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}.

U. Singh, S. Devaraj, I. Jialal, 2005, Diabetes.

Jupiter to Earth: CRP promotes atherothrombosis.

S. Devaraj, I. Jialal, 2009, Metabolic syndrome and related disorders.

Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance.

S. Verma, S. Devaraj, I. Jialal, 2009, Clinical chemistry.

Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.

S. Grundy, S. Devaraj, I. Jialal, 2001, Metabolism: clinical and experimental.

Prospective vitamin E clinical trials.

K. Kraemer, L. Packer, M. Traber, 2002 .

Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes.

I. Jialal, Daniella Lent-Schochet, M. McLaughlin, 2019, Clinica chimica acta; international journal of clinical chemistry.

Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?

S. Devaraj, I. Jialal, 2005, Nutrition reviews.

Coenzyme Q10 supplementation and heart failure.

U. Singh, S. Devaraj, I. Jialal, 2007, Nutrition reviews.

Coenzyme Q 10 and Its Role in Cardiomyopathy and Heart Failure in Adults

U. Singh, S. Devaraj, I. Jialal, 2007 .

Ishwarlal Jialal Inhibition of 5-Lipoxygenase Release From Activated Human Monocytes by β-Tocopherol Decreases Interleukin-1

S. Devaraj, I. Jialal, 1999 .

Physiology, Acute Phase Reactants

I. Jialal, M. Ashraf, Radhika Gulhar, 2019 .

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

S. Devaraj, I. Jialal, M. Feldman, 2001, Journal of the American College of Cardiology.

Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults.

J. Rutherford, I. Jialal, N. Sharma, 2001, The American journal of cardiology.

Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo.

L. Kuo, U. Singh, T. Hein, 2009, Atherosclerosis.

Oxidative Stress, Inflammation, and Diabetic Vasculopathies: The Role of Alpha Tocopherol Therapy

S. Devaraj, I. Jialal, S. Venugopal, 2002, Free radical research.

Effects of epigallocatechin gallate on regulatory T cell number and function in obese versus lean volunteers

I. Jialal, Jung-Mi Yun, 2010, British Journal of Nutrition.

Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.

P. Tobias, S. Devaraj, I. Jialal, 2011, Cytokine.

Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.

U. Singh, S. Devaraj, I. Jialal, 2008, The American journal of cardiology.

Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis.

I. Jialal, S. Raychaudhuri, M. Kaur, 2010, Metabolic syndrome and related disorders.

Excessive hypercortisolemia due to ectopic Cushing’s syndrome requiring extending the reportable range for plasma cortisol for management

I. Jialal, A. Furman, 2017, Clinical chemistry and laboratory medicine.

Nonspecific elevation of troponin T levels in patients with chronic renal failure.

I. Jialal, J. Keffer, M. Vázquez, 1995, Clinical biochemistry.

Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

I. Jialal, H. Kaur, Alexander Chien, 2012, American journal of physiology. Renal physiology.

Hyperglycemia induced Toll like receptor 4 Expression and Activity in Mouse Mesangial

I. Jialal, H. Kaur, Alexander Chien, 2012 .

Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile

S. Vega-López, P. Rohdewald, S. Devaraj, 2002, Lipids.

Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM

S. Haffner, M. Stern, L. Mykkanen, 1995, Diabetes Care.

Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation.

B. Adams-Huet, I. Jialal, Frank L Duong, 2014, Metabolic syndrome and related disorders.

A comparison of the ratios of C-reactive protein and triglycerides to high-density lipoprotein-cholesterol as biomarkers of metabolic syndrome in African Americans and non-Hispanic Whites.

B. Adams-Huet, A. Remaley, I. Jialal, 2022, Journal of diabetes and its complications.

Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian origin.

G. Coetzee, D. Rubinsztein, I. Jialal, 1993, Biochimica et biophysica acta.

Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines.

B. Adams-Huet, S. Devaraj, I. Jialal, 2014, Metabolic syndrome and related disorders.

Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.

S. Grundy, G. Vega, I. Jialal, 1990, Atherosclerosis.

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.

S. Griffen, S. Devaraj, I. Jialal, 2006, Diabetes.

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

L. Packer, O. Tirosh, S. Devaraj, 1999 .

RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2).

S. Devaraj, I. Jialal, S. Venugopal, 2004, Atherosclerosis.

PCSK9 inhibitors: the next frontier in low-density lipoprotein lowering.

Shailendra B. Patel, I. Jialal, S. Patel, 2015, Metabolic syndrome and related disorders.

The Effect of α-Tocopherol on Monocyte Proatherogenic Activity

S. Devaraj, I. Jialal, N. Kaul, 2001 .

Endothelial Cells-Tocopherol Enrichment of Monocytes Decreases Agonist-Induced Adhesion to Human

S. Devaraj, I. Jialal, 1998 .

Leukocytes, platelets and cardiovascular diseases.

B. Adams-Huet, I. Jialal, 2021, Atherosclerosis.

Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome

B. Adams-Huet, I. Jialal, Julie Shafer-Eggleton, 2020, Endocrine research.

Metabolites that activate the inflammasome in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2020, Journal of diabetes and its complications.

The platelet to high density lipoprotein ‐cholesterol ratio is a valid biomarker of nascent metabolic syndrome

B. Adams-Huet, I. Jialal, G. Jialal, 2020, Diabetes/metabolism research and reviews.

Potential implications of redefining the hypertriglyceridemia of metabolic syndrome

S. Devaraj, I. Jialal, 2019, Hormone molecular biology and clinical investigation.

The relationship between tyramine levels and inflammation in metabolic syndrome

B. Adams-Huet, I. Jialal, Ajay Patel, 2019, Hormone molecular biology and clinical investigation.

Exploratory metabolomics of nascent metabolic syndrome.

I. Jialal, Kyumin Shim, Radhika Gulhar, 2019, Journal of diabetes and its complications.

Subcutaneous adipose tissue biology in metabolic syndrome

S. Devaraj, I. Jialal, 2018, Hormone molecular biology and clinical investigation.

Increased fibrosis and angiogenesis in subcutaneous gluteal adipose tissue in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2017, Diabetes & metabolism.

Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.

B. Adams-Huet, I. Jialal, D. Siegel, 2017, Journal of diabetes and its complications.

Factors that promote macrophage homing to adipose tissue in metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2016, Journal of diabetes and its complications.

Monocyte cell adhesion molecule receptors in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2016, Clinical biochemistry.

Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2015, Metabolic syndrome and related disorders.

Cellular Signaling in Metabolic Syndrome.

I. Jialal, R. Pahwa, 2015, Metabolic syndrome and related disorders.

Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome.

F. Haj, B. Adams-Huet, S. Devaraj, 2015, Atherosclerosis.

Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2013, The Journal of clinical endocrinology and metabolism.

Bariatric surgery for the metabolic syndrome: magic bullet or not?

I. Jialal, S. Dhindsa, 2012, Metabolic syndrome and related disorders.

Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2012, The Journal of clinical endocrinology and metabolism.

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome

S. Devaraj, I. Jialal, H. Kaur, 2012, Diabetes Care.

The tenth anniversary of metabolic syndrome and related disorders.

I. Jialal, 2012, Metabolic syndrome and related disorders.

The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes

S. Devaraj, I. Jialal, R. Pahwa, 2016, International Journal of Obesity.

Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.

S. Devaraj, I. Jialal, R. Burk, 2001, Clinical chemistry.

Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis.

S. Devaraj, I. Jialal, D. Rainwater, 2003, American journal of clinical pathology.

Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation?

I. Jialal, S. Dhindsa, 2016, Atherosclerosis.

Influence of Antioxidant Vitamins on LDL Oxidation a

S. Grundy, I. Jialal, 1992, Annals of the New York Academy of Sciences.

Insulin receptor regulation and desensitization in rat hepatoma cells. The loss of the oligomeric forms of the receptor correlates with the change in receptor affinity.

C. Kahn, M. Kasuga, I. Jialal, 1984, The Journal of biological chemistry.

DPP-4 inhibitors and atherosclerosis: the promise.

M. Bajaj, I. Jialal, 2013, Atherosclerosis.

Varying susceptibility of different low density lipoproteins to oxidative modification.

S. Grundy, I. Jialal, D. Freeman, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

S. Devaraj, I. Jialal, D. Siegel, 2007, The American journal of cardiology.

Simvastatin (40mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects with the Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2007 .

A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.

G. Chiesa, I. Jialal, C. Scaccini, 1994, Journal of lipid research.

Cyclosporin A does not increase the oxidative susceptibility of low density lipoprotein in vitro.

S. Devaraj, I. Jialal, M. Vázquez, 1999, Free radical biology & medicine.

LDL modification by activated polymorphonuclear leukocytes: a cellular model of mild oxidative stress.

I. Jialal, C. Scaccini, 1994, Free radical biology & medicine.

The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study.

I. Jialal, C. Fuller, B. Huet, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Pseudoinsulinoma in a white man with autoimmune hypoglycemia due to anti-insulin antibodies: value of the free C-Peptide assay.

I. Jialal, U. Rajamani, Audrey E. Arzamendi, 2014, American journal of clinical pathology.

Superoxide production and LDL oxidation by diabetic neutrophils.

I. Jialal, D. Lender, C. Fuller, 1996, Journal of diabetes and its complications.

Measurement of lipid-soluble vitamins-further adjustment needed?

M. Traber, I. Jialal, 2000, The Lancet.

Editor's perspective on metabolic syndrome for 2008.

I. Jialal, 2008, Metabolic syndrome and related disorders.

The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors.

I. Jialal, A. Swislocki, 2015, Metabolic syndrome and related disorders.

Plasma oxidizability in Mexican-Americans and non-Hispanic whites.

S. Haffner, H. Miettinen, M. Stern, 1996, Metabolism: clinical and experimental.

Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages.

S. Devaraj, I. Jialal, I. Hugou, 2001, Journal of lipid research.

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes

S. Devaraj, I. Jialal, M. Dasu, 2009, Diabetologia.

Diagnosis of Familial Hypercholesterolemia.

I. Jialal, P. Barton Duell, 2016, American journal of clinical pathology.

Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.

S. Devaraj, I. Jialal, Basir Syed, 2012, American journal of clinical pathology.

Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats

S. Devaraj, I. Jialal, H. Kaur, 2013, Diabetes & vascular disease research.

Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats.

S. Devaraj, I. Jialal, H. Kaur, 2013, Journal of diabetes and its complications.

Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats

S. Devaraj, I. Jialal, 2012, Diabetes & vascular disease research.

Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications.

S. Devaraj, I. Jialal, A. Bremer, 2011, Metabolism: clinical and experimental.

Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

S. Devaraj, I. Jialal, 2009, Cytokine.

Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis.

S. Verma, S. Devaraj, I. Jialal, 2006, Circulation.

Is vitamin C an antiinflammatory agent?

U. Singh, I. Jialal, 2006, The American journal of clinical nutrition.

Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones.

K. Yeum, Elizabeth J Johnson, A. Lichtenstein, 2005, The American journal of clinical nutrition.

No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations.

I. Jialal, S. Dhindsa, 2014, Metabolic syndrome and related disorders.

Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies.

R. Bucala, S. Devaraj, I. Jialal, 1996, Journal of lipid research.

Opinion Paper: Is the Fiedewald equation obsolete?

I. Jialal, W. Winter, 2020, Clinica chimica acta; international journal of clinical chemistry.

Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats** This work was supported by National Institutes of Health Grant RO1 HL-074360 to I. J. Published, JLR Papers in Press, February 2, 2008.

P. Yancey, U. Singh, S. Devaraj, 2008, Journal of Lipid Research.

Troponin I in hypothyroidism.

L. Cohen, I. Jialal, J. Keffer, 1996, Clinical chemistry.

Vitamin D deficiency of unknown etiology

I. Jialal, M. E. Allen, 2015 .

AHA/ACC/Multisociety Cholesterol Guidelines: highlights

S. Devaraj, I. Jialal, 2019, Therapeutic advances in cardiovascular disease.

Therapy and clinical trials: management of diabetic dyslipidemia.

M. Bajaj, I. Jialal, 2009, Current opinion in lipidology.

beta-Carotene inhibits the oxidative modification of low-density lipoprotein.

S. Grundy, E. Norkus, I. Jialal, 1991, Biochimica et biophysica acta.

Pituitary Function and Pathophysiology

M. Vance, I. Jialal, W. Winter, 2012 .

Validation of an immunoassay for measurement of plasma total homocysteine.

S. Devaraj, I. Jialal, D. O’Byrne, 1999, American journal of clinical pathology.

How specific is cardiac troponin?

A. Wu, I. Jialal, 2000, American journal of clinical pathology.

Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation.

I. Jialal, C. Fuller, B. Huet, 1998, The American journal of cardiology.

Asymptomatic Isolated Human Glycerol Kinase Deficiency Associated with Splice-Site Mutations and Nonsense-Mediated Decay of Mutant RNA

E. McCabe, K. Dipple, H. Northrup, 2006, Pediatric Research.

Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo.

I. Jialal, M. Dasu, Andrea C Riosvelasco, 2009, Atherosclerosis.

Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.

S. Griffen, S. Devaraj, I. Jialal, 2008, The Journal of clinical endocrinology and metabolism.

Is vitamin C an antiinflammatory agent ? 1 – 3

U. Singh, I. Jialal, 2006 .

Adiponectin Decreases C-Reactive Protein Synthesis and Secretion From Endothelial Cells: Evidence for an Adipose Tissue-Vascular Loop

Natalie J Torok, S. Devaraj, I. Jialal, 2008, Arteriosclerosis, thrombosis, and vascular biology.

The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells Published, JLR Papers in Press, December 11, 2006.

T. D. Du Clos, S. Devaraj, I. Jialal, 2007, Journal of Lipid Research.

C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production

J. Reusch, U. Singh, S. Devaraj, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.

P. Nallasamy, I. Jialal, R. Pahwa, 2016, Journal of diabetes and its complications.

A Randomized Placebo-Controlled Crossover trial of Aloe Vera on Bioavailability of Vitamins C and B12, Blood Glucose, and Lipid Profile in Healthy Human Subjects

S. Devaraj, I. Jialal, Jason Rockwood, 2010, Journal of dietary supplements.

The role of oxidized low density lipoprotein in atherogenesis.

S. Devaraj, I. Jialal, 1996, The Journal of nutrition.

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

I. Jialal, N. Vikram, 2021, Therapeutic advances in cardiovascular disease.

C-Reactive Protein Stimulates Myeloperoxidase Release from Polymorphonuclear Cells and Monocytes

U. Singh, S. Devaraj, I. Jialal, 2008 .

Is there a vitamin E paradox?

M. Traber, S. Devaraj, I. Jialal, 2001, Current opinion in lipidology.

Non-insulin dependent diabetes in the young is not linked to the insulin gene.

I. Jialal, 1983, British medical journal.

RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.

S. Grundy, M. Chandalia, I. Jialal, 1996, The American journal of clinical nutrition.

Both the platelet count and the platelet: lymphocyte ratio are not increased in nascent metabolic syndrome

B. Adams-Huet, I. Jialal, G. Jialal, 2019, Platelets.

CD11c/CD18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1

R. Gower, S. Simon, C. Ballantyne, 2011, Arteriosclerosis, thrombosis, and vascular biology.

CD 11 c / CD 18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1

R. Gower, S. Simon, C. Ballantyne, 2010 .

Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome.

G. Fadini, S. Devaraj, I. Jialal, 2010, The American journal of cardiology.

Endothelial progenitor cell status in metabolic syndrome.

I. Jialal, 2010, Metabolic syndrome and related disorders.

The Paradox of Increased Trimethylamine-N-Oxide Levels Following Bariatric Surgery.

S. Devaraj, I. Jialal, 2016, Metabolic syndrome and related disorders.

Diabetes Mellitus Type 2

R. Goyal, I. Jialal, 2019 .

Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.

I. Jialal, Gerred Smith, 2012, Metabolic syndrome and related disorders.

Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids.

S. Devaraj, B. Rao, I. Jialal, 2013, Atherosclerosis.

Vitamin E supplementation and cardiovascular events in high-risk patients.

S. Devaraj, I. Jialal, 2000, The New England journal of medicine.

Effect of Combined Supplementation With C‐Tocopherol, Ascorbate, and Beta Carotene on Low‐Densit Lipoprotein Oxidation

S. Grundy, I. Jialal, L. Jialal, 1993 .

Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.

N. Abate, I. Jialal, 2015, Metabolic syndrome and related disorders.

C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo.

U. Singh, S. Devaraj, I. Jialal, 2009, Atherosclerosis.

An African American Male Patient with Rare Type B Insulin Resistance Syndrome.

S. Devaraj, I. Jialal, 2021, Laboratory medicine.

Modern Management of Familial Hypercholesterolemia.

I. Jialal, P. Duell, 2016, Metabolic syndrome and related disorders.

Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome

I. Jialal, Daniella Lent-Schochet, M. McLaughlin, 2018, Hormone molecular biology and clinical investigation.

Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.

S. Devaraj, I. Jialal, A. Major, 2014, Journal of diabetes and its complications.

Preliminary Report of Inflammatory Markers, Oxidative Stress, and Insulin Resistance in Adolescents of Different Ethnicities.

M. Dharmar, S. Devaraj, I. Jialal, 2016, Metabolic syndrome and related disorders.

Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress.

L. Packer, O. Tirosh, S. Devaraj, 1999, Free radical biology & medicine.

Low vitamin D levels in Northern American adults with the metabolic syndrome.

S. Devaraj, I. Jialal, D. Siegel, 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.

S. Devaraj, I. Jialal, 2020, Annals of clinical and laboratory science.

Erratum: Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes (Clinical Chemistry (2001) 47 (1974-1979))

S. Devaraj, I. Jialal, S. Hirany, 2002 .

Senthil Kumar Venugopal , Sridevi Devaraj and Ishwarlal Jialal C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

S. Devaraj, I. Jialal, S. Venugopal, 2003 .

Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis.

I. Jialal, C. Fuller, Fuller Cj, 1995, The Canadian journal of cardiology.

Evaluation of a rapid homogeneous method for direct measurement of high-density lipoprotein cholesterol.

S. Devaraj, I. Jialal, S. Hirany, 1998, American journal of clinical pathology.

Therapy and clinical trials.

S. Devaraj, I. Jialal, 2007, Current opinion in lipidology.

Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects.

S. Grundy, S. Devaraj, I. Jialal, 2001, The American journal of cardiology.

Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.

I. Jialal, M. Dasu, 2013, Journal of diabetes and its complications.

Editorial comment Therapy and clinical trials

I. Jialal, L. Berglund, 2001 .

Remnant lipoproteins: measurement and clinical significance.

S. Devaraj, I. Jialal, 2002, Clinical chemistry.

High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy.

J. D. de Lemos, U. Singh, J. Otvos, 2007, Clinical chemistry.

Update on Lipids and Lipoproteins.

S. Devaraj, I. Jialal, 2021, JAMA.

Increased neutrophil count in nascent metabolic syndrome.

B. Adams-Huet, I. Jialal, H. Kaur, 2013, Metabolic syndrome and related disorders.

Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction.

I. Jialal, C. Fuller, A. Agil, 1995, Clinical chemistry.

Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein.

R. Kitsis, I. Jialal, 2006, The New England journal of medicine.

Measurement of protein carbonyls in plasma of smokers and in oxidized LDL by an ELISA.

S. Devaraj, I. Jialal, Karine Marangon, 1999, Clinical chemistry.

Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress.

I. Jialal, R. Pahwa, 2016, Metabolic syndrome and related disorders.

Cadmium and atherosclerosis: Heavy metal or singing the blues?

I. Jialal, C. Santos-Gallego, 2016, Atherosclerosis.

The evolving role of toll-like receptors in diabetic vascular complications.

I. Jialal, R. Pahwa, 2015, Journal of diabetes and its complications.

Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation.

B. Adams-Huet, S. Devaraj, I. Jialal, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Severe Hyperglycemia Down Regulates Toll‐Like Receptors on Neutrophils: Implications for Propensity to Infections in Diabetics

S. Devaraj, C. Polage, I. Jialal, 2013 .

Polyglandular Autoimmune Syndrome Type II

I. Jialal, Gurdeep Singh, 2020 .

Polyglandular Autoimmune Syndrome, Type II (Carpenters, Schmidt)

I. Jialal, Gurdeep Singh, 2018 .

Validation of Fibroblast Growth Factor 23 Assays.

I. Jialal, 2020, The journal of applied laboratory medicine.

Statin Intolerance in a Patient with Gilberts Syndrome and Hypercholesterolemia

I. Jialal, D. Siegel, MD I. Jialal, 2016, Experimental and Clinical Endocrinology & Diabetes Reports.

Secretory tumors of the pituitary gland: a clinical biochemistry perspective

I. Jialal, V. Gounden, Y. Rampursat, 2018, Clinical chemistry and laboratory medicine.

Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.

S. Devaraj, I. Jialal, Jung-Mi Yun, 2012, The Journal of nutritional biochemistry.

A pilot randomized placebo controlled trial of 2 Aloe vera supplements in patients with pre-diabetes/metabolic syndrome

S. Devaraj, I. Jialal, Jason Rockwood, 2008 .

Folate Insufficiency Due to Celiac Disease in a 49-Year-Old Woman of Southeast Asian-Indian Ethnicity.

Asha Gupta, I. Jialal, Ananya Datta Mitra, 2016, Laboratory medicine.

Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome.

M. Yimam, Q. Jia, S. Devaraj, 2013, Metabolic syndrome and related disorders.

Vitamin E, oxidative stress, and inflammation.

U. Singh, S. Devaraj, I. Jialal, 2005, Annual review of nutrition.

The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.

S. Devaraj, I. Jialal, D. Li, 1996, The Journal of clinical investigation.

Physiology, Endocrine Hormones

I. Jialal, M. Campbell, 2019 .

Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents.

J. Tabibian, U. Singh, S. Devaraj, 2005, Clinical chemistry.

Laboratory investigation of disorders of the pituitary gland

I. Jialal, V. Gounden, Charlotte C Ellberg, 2021 .

Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans

S. Grundy, L. Packer, M. Traber, 2000 .

A Dose-Response Study on the Effects of Purified Lycopene Supplementation on Biomarkers of Oxidative Stress

Sridevi Devaraj, H. Aung, S. Devaraj, 2008, Journal of the American College of Nutrition.

Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure.

I. Jialal, J. Keffer, D. Li, 1996, Clinical chemistry.

Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call

I. Jialal, V. Gounden, 2017, Clinical chemistry and laboratory medicine.

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes

S. Devaraj, Ling Zhao, I. Jialal, 2008, Diabetes.

Effect of C-reactive protein on chemokine expression in human aortic endothelial cells.

S. Devaraj, I. Jialal, P. Kumaresan, 2004, Journal of molecular and cellular cardiology.

Innate Immunity Genes Influence the Severity of Acute Appendicitis

G. O’Keefe, G. Lindberg, R. Munford, 2004, Annals of surgery.

Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults.

S. Grundy, S. Devaraj, I. Jialal, 2002, The American journal of clinical nutrition.

Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis.

B. Adams-Huet, S. Devaraj, I. Jialal, 2019, American journal of physiology. Endocrinology and metabolism.

C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis

S. Devaraj, I. Jialal, Dan Xu, 2003, Circulation.

α-tocopherol decreases tumor necrosis factor-α mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase

S. Devaraj, I. Jialal, 2005 .

Supplementation with ω3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers ☆

S. Vega-López, Bruce J. German, S. Devaraj, 2004 .

Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice

R. A. Luna, S. Devaraj, I. Jialal, 2017, Journal of diabetes research.

The evolving role of C-reactive protein in atherothrombosis.

Sridevi Devaraj, U. Singh, S. Devaraj, 2009, Clinical chemistry.

Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role

S. Devaraj, I. Jialal, S. Venugopal, 2005, Current opinion in nephrology and hypertension.

Comparison of cardiac troponin I and lactate dehydrogenase isoenzymes for the late diagnosis of myocardial injury.

I. Jialal, J. Keffer, D. Li, 1996, American journal of clinical pathology.

ATVB In Focus Nutrition and Atherosclerosis

S. Devaraj, I. Jialal, A. Basu, 2006 .

Therapy and clinical trials.

N. Abate, I. Jialal, 2001, Current opinion in lipidology.

Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

S. Grundy, B. Adams-Huet, S. Devaraj, 2001, Circulation.

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome.

C. Keen, S. Devaraj, I. Jialal, 2008, Metabolism: clinical and experimental.

Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker.

G. O’Keefe, S. Devaraj, I. Jialal, 2005, The Journal of clinical endocrinology and metabolism.

Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy

B. Kasinath, P. Tobias, S. Devaraj, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome

S. Devaraj, I. Jialal, R. Pahwa, 2020, Diabetes/metabolism research and reviews.

Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome.

S. Devaraj, I. Jialal, Jason Rockwood, 2008, Metabolic syndrome and related disorders.

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

S. Devaraj, I. Jialal, S. Venugopal, 2003, Circulation.

Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

Sridevi Devaraj, I. Yuhanna, P. Shaul, 2002, Circulation.

Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications The Effect of α-Tocopherol Supplementation

Sridevi Devaraj, S. Devaraj, I. Jialal, 2000 .

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2010, Current atherosclerosis reports.

Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.

S. Devaraj, I. Jialal, I Jialal, 2000, Circulation.

α-Tocopherol Enrichment of Monocytes Decreases Agonist-Induced Adhesion to Human Endothelial Cells

S. Devaraj, I. Jialal, K. Islam, 1998 .

Oxidative Stress and Antioxidant Supplementation in the Management of Diabetic Cardiovascular Disease

S. Vega-López, S. Devaraj, I. Jialal, 2004, Journal of Investigative Medicine.

The role of C-reactive protein activation of nuclear factor kappa-B in the pathogenesis of unstable angina.

S. Devaraj, I. Jialal, 2007, Journal of the American College of Cardiology.

α-Tocopherol decreases CD36 expression in human monocyte-derived macrophages

S. Devaraj, I. Jialal, I. Hugou, 2001 .

Diabetes is a proinflammatory state: a translational perspective

S. Devaraj, I. Jialal, M. Dasu, 2010, Expert review of endocrinology & metabolism.

Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease.

S. Devaraj, I. Jialal, Catherine Duncan-Staley, 2010, Metabolic syndrome and related disorders.

Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein.

I. Jialal, 1998, Clinical chemistry.

TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice

I. Jialal, M. Dasu, L. DiPietro, 2010, Laboratory Investigation.

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

S. Devaraj, I. Jialal, M. Dasu, 2010, Diabetes Care.

Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.

I. Jialal, B. Mehrad, W. Vongpatanasin, 2003, Journal of the American College of Cardiology.

Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.

S. Devaraj, I. Jialal, M. Dasu, 2009, Endocrinology.

Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects.

S. Devaraj, I. Jialal, S. Venugopal, 2005, The American journal of pathology.

Anti‐inflammatory Effects of α‐Tocopherol

U. Singh, I. Jialal, 2004 .

C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?

S. Devaraj, I. Jialal, S. Venugopal, 2004, Hypertension.

Letter to the Editor from Jialal and Sood: "New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation Using Specific Cortisol Assays".

I. Jialal, A. Sood, 2021, Journal of the Endocrine Society.

The effect of alpha-tocopherol on monocyte proatherogenic activity.

S. Devaraj, I. Jialal, N. Kaul, 2001, Journal of NutriLife.

Non-insulin-dependent diabetes in young Indians : a clinical and biochemical study.

I. Jialal, 1982 .

Thyrotropin receptor antibody assays: clinical utility.

S. Devaraj, I. Jialal, W. Winter, 2013, American journal of clinical pathology.

Biochemistry, Immunoglobulin A

I. Jialal, Ajay Patel, 2020 .

Multiple Endocrine Neoplasia Type 1 (MEN I, Wermer Syndrome)

I. Jialal, Gurdeep Singh, Neelam J. Mulji, 2019 .

Physiology, Thyroid Stimulating Hormone (TSH)

I. Jialal, Yasaman Pirahanchi, 2020 .

C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.

Sridevi Devaraj, U. Singh, S. Devaraj, 2009, Clinical chemistry.

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.

U. Singh, S. Devaraj, I. Jialal, 2007, Journal of molecular and cellular cardiology.

Adipose Tissue Dysfunction in Nascent Metabolic Syndrome

I. Jialal, A. Bremer, 2013, Journal of obesity.

Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome

B. Adams-Huet, I. Jialal, N. Ramakrishnan, 2020, Hormone molecular biology and clinical investigation.

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.

S. Devaraj, I. Jialal, I Jialal, 2001, American journal of clinical pathology.

Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women.

P. Fadel, I. Jialal, W. Vongpatanasin, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Hyperglycemia Induces Monocytic Release of Interleukin-6 via Induction of Protein Kinase C-α and -β

U. Singh, S. Devaraj, I. Jialal, 2005 .

Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.

S. Leonard, M. Traber, S. Devaraj, 2008, Free radical biology & medicine.

Nontraditional risk factors for cardiovascular disease in diabetes.

V. Fonseca, C. DeSouza, C. Desouza, 2004, Endocrine reviews.

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications

R. Bonow, S. Hunt, P. O'Gara, 2002, Circulation.

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis.

I. Jialal, 2006, Critical pathways in cardiology.

Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.

S. Griffen, S. Devaraj, I. Jialal, 2007, The Journal of clinical endocrinology and metabolism.

Statins and biomarkers of inflammation

S. Devaraj, I. Jialal, J. Rogers, 2007, Current atherosclerosis reports.

Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome.

S. Devaraj, I. Jialal, E. Chan, 2006, The Journal of clinical endocrinology and metabolism.

Chapter 9 – Effects of Statins on C-Reactive Protein: Are All Statins Similar?

S. Devaraj, I. Jialal, 2004 .

Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications

S. Devaraj, I. Jialal, 2000 .

The Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study

I. Jialal, C. Fuller, B. Huet, 1995 .

Standardization of lipoprotein reporting.

N. Rifai, G. Cooper, T. Cole, 2000, American journal of clinical pathology.

Jialal-Tocopherol Supplementation α Complications : The Effect of Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Low-Density Lipoprotein Postsecretory Modification , Monocyte Function , and Circulating

S. Devaraj, I. Jialal, 2000 .

Processing of Insulin by Bovine Endothelial Cells in Culture: Internalization Without Degradation

C. Kahn, I. Jialal, M. Crettaz, 1984, Diabetes.

Fetuin-A is also an adipokine

I. Jialal, R. Pahwa, 2019, Lipids in Health and Disease.

The neutrophil count is superior to the neutrophil/lymphocyte ratio as a biomarker of inflammation in nascent metabolic syndrome

B. Adams-Huet, I. Jialal, 2019, Annals of clinical biochemistry.

C-Reactive Protein Decreases Tissue Plasminogen Activator Activity in Human Aortic Endothelial Cells: Evidence that C-Reactive Protein Is a Procoagulant

U. Singh, S. Devaraj, I. Jialal, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Oxidative stress and atherosclerosis.

U. Singh, I. Jialal, 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

Inflammation and Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2011 .

Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status.

R. Rosenson, S. Devaraj, I. Jialal, 2004, Endocrinology and metabolism clinics of North America.

Management of diabetic dyslipidemia: An update

I. Jialal, Gurdeep Singh, 2019, World journal of diabetes.

Chapter 8 – Diabetes and Inflammation

M. Chandalia, S. Devaraj, I. Jialal, 2006 .

Coronary Artery Disease Effects of Low-Dose Aspirin on Serum C-Reactive Protein and Thromboxane B 2 Concentrations : A Placebo-Controlled Study Using a Highly Sensitive C-Reactive Protein Assay

S. Devaraj, I. Jialal, M. Feldman, 2016 .

The effect of weight loss and dietary fatty acids on inflammation

S. Kasim-Karakas, S. Devaraj, I. Jialal, 2006, Current atherosclerosis reports.

Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States.

S. Grundy, N. Abate, M. Chandalia, 2003, The Journal of clinical endocrinology and metabolism.

Hyperhomocysteinemia in Asian Indians living in the United States.

S. Grundy, N. Abate, M. Chandalia, 2003, The Journal of clinical endocrinology and metabolism.

Modulation of Monocyte‐Macrophage Function with α‐Tocopherol: Implications for Atherosclerosis

S. Devaraj, I. Jialal, A. Harris, 2002 .

Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis.

S. Devaraj, I. Jialal, A. Harris, 2002, Nutrition reviews.

Human C-reactive protein and the metabolic syndrome

U. Singh, S. Devaraj, I. Jialal, 2009, Current opinion in lipidology.

Role of C-reactive protein in the assessment of cardiovascular risk.

S. Devaraj, I. Jialal, 2003, The American journal of cardiology.

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy

I. Jialal, U. Rajamani, 2014, Journal of diabetes research.

The role of the high-mobility group box1 protein-Toll like receptor pathway in diabetic vascular disease.

I. Jialal, R. Pahwa, 2016, Journal of diabetes and its complications.

A practical approach to the laboratory diagnosis of dyslipidemia.

I. Jialal, 1996, American journal of clinical pathology.

Antioxidants and atherosclerosis: don't throw out the baby with the bath water.

S. Devaraj, I. Jialal, 2003, Circulation.

Nutrition therapy for diabetes: Implications for decreasing cardiovascular complications.

I. Jialal, N. Vikram, 2017, Journal of diabetes and its complications.

Impaired Bilirubin Conjugation

I. Jialal, N. Ramakrishnan, 2019 .

Diabetic Perioperative Management

I. Jialal, P. Dogra, 2019 .

The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome

B. Adams-Huet, I. Jialal, 2021, Endocrine research.

Inflammation, Atherosclerosis, and Psoriasis

S. Devaraj, I. Jialal, S. Raychaudhuri, 2013, Clinical Reviews in Allergy & Immunology.

Therapeutic lifestyle change intervention improved metabolic syndrome criteria and is complementary to amlodipine/atorvastatin.

N. Abate, M. Chandalia, I. Jialal, 2019, Journal of diabetes and its complications.

Dysregulation of monocyte biology in metabolic syndrome

S. Devaraj, I. Jialal, U. Rajamani, 2014, Expert review of endocrinology & metabolism.

Adipose tissue dysregulation in patients with metabolic syndrome.

S. Devaraj, I. Jialal, A. Bremer, 2011, The Journal of clinical endocrinology and metabolism.

Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.

S. Devaraj, I. Jialal, 2000, Free radical biology & medicine.

The triglyceride-waist circumference index is a valid biomarker of metabolic syndrome in African Americans.

B. Adams-Huet, A. Remaley, I. Jialal, 2022, The American journal of the medical sciences.

CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.

B. Adams-Huet, U. Singh, S. Devaraj, 2008, American journal of clinical pathology.

Effect of alpha tocopherol supplementation on monocyte function

I. Jialal, S. Devaral, 1996 .

Biochemistry, Low Density Lipoprotein

I. Jialal, S. Venugopal, 2019 .

A more valid measurement of low-density lipoprotein cholesterol in diabetic patients.

I. Jialal, S. Hirany, D. Li, 1997, The American journal of medicine.

Lipid management in clinical practice.

S. Devaraj, I. Jialal, 2009, Current opinion in lipidology.

Statin therapy for the metabolic syndrome: the evidence base.

S. Devaraj, I. Jialal, 2009, Metabolic syndrome and related disorders.

CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions.

S. Simon, S. Devaraj, I. Jialal, 2006, American journal of physiology. Heart and circulatory physiology.

Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.

I. Jialal, M. Dasu, 2011, American journal of physiology. Endocrinology and metabolism.

Decreased homoserine levels in metabolic syndrome.

I. Jialal, Ajay Patel, A. Thompson, 2020, Diabetes & metabolic syndrome.

C‐reactive protein induces M‐CSF release and macrophage proliferation

S. Devaraj, I. Jialal, Jung-Mi Yun, 2009, Journal of leukocyte biology.

Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity.

B. Adams-Huet, I. Jialal, H. Kaur, 2014, Atherosclerosis.

The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications

I. Jialal, H. Kaur, 2012, Current Diabetes Reports.

Increased eosinophils in adipose tissue of metabolic syndrome.

B. Adams-Huet, S. Devaraj, I. Jialal, 2019, Journal of diabetes and its complications.

Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications

A. Cheung, T. Aoki, S. Griffen, 2007, Diabetes.

CRP Induces Release of Both Endothelial Microparticles and Circulating Endothelial Cells In Vitro and In Vivo: Further Evidence of Endothelial Dysfunction

S. Devaraj, I. Jialal, P. Kumaresan, 2011 .

CHAPTER 33 – Modulation of Biomarkers of Inflammation

S. Devaraj, I. Jialal, 2009 .

Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein.

S. Devaraj, I. Jialal, S. Venugopal, 2006, Atherosclerosis.

Binding and Internalization of C-Reactive Protein by Fcgamma Receptors on Human Aortic Endothelial Cells Mediates Biological Effects

T. D. Du Clos, S. Devaraj, I. Jialal, 2005, Arteriosclerosis, thrombosis, and vascular biology.

alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells.

S. Devaraj, I. Jialal, K. Islam, 1998, Circulation.

Correlates of Insulin Resistance in Nascent Metabolic Syndrome

B. Adams-Huet, I. Jialal, 2023, Clinical medicine insights. Endocrinology and diabetes.

CRP induces hypertension in animal models: homo sapiens says NO

S. Devaraj, I. Jialal, D. Siegel, 2011, Hypertension Research.

Endotoxemia of metabolic syndrome: a pivotal mediator of meta-inflammation.

I. Jialal, U. Rajamani, 2014, Metabolic syndrome and related disorders.

Concomitant Reduction of LDL-Cholesterol and Biomarkers of Inflammation with Low Dose Simvastatin Therapy in Patients with Type 1 Diabetes

S. Griffen, S. Devaraj, I. Jialal, 2007 .

a-Tocopherol decreases CD 36 expression in human monocyte-derived macrophages

S. Devaraj, I. Jialal, I. Hugou, 2001 .

Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.

S. Grundy, G. Vega, S. Devaraj, 1998, The American journal of medicine.

The role of dyslipidemia in diabetic retinopathy: a brighter focus?

I. Jialal, D. Siegel, U. Rajamani, 2014, Journal of diabetes and its complications.

Bempedoic acid: a novel oral LDL-cholesterol lowering agent.

I. Jialal, N. Ramakrishnan, 2022, International journal of physiology, pathophysiology and pharmacology.

Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.

S. Grundy, K. Kraemer, L. Packer, 2000, Free radical biology & medicine.

Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia.

I. Jialal, Michael Miller, 2002, The American journal of cardiology.

Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

A. Remaley, I. Jialal, 2014, Clinical pharmacology and therapy.

Alpha-tocopherol and atherosclerosis.

S. Devaraj, I. Jialal, N. Kaul, 2001, Experimental biology and medicine.

Effect of aging on susceptibility of low-density lipoproteins to oxidation.

S. Devaraj, I. Jialal, C. Fuller, 1995, Clinical chemistry.

A Patient with Genetic Bisalbuminemia.

I. Jialal, Pratik Shah, Edward Cagampan, 2021, American Journal of the Medical Sciences.

Measurement of β1- and β2-Globulins Improves Detection of M-Spikes on High-Resolution Electrophoresis

S. Devaraj, I. Jialal, C. Rutherford, 2003 .

Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity.

S. Devaraj, I. Jialal, 2008, Archives of pathology & laboratory medicine.

Processing and transport of insulin by vascular endothelial cells. Effects of sulfonylureas on insulin receptors.

G. King, I. Jialal, S. Johnson, 1985, The American journal of medicine.

The role of the laboratory in the diagnosis of the metabolic syndrome.

I. Jialal, Ishwarlal Jialal, 2009, American journal of clinical pathology.

Anti-inflammatory effects of alpha-tocopherol.

U. Singh, I. Jialal, 2004, Annals of the New York Academy of Sciences.

Corrigendum to "Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes" [Cytokine 55 (2011) 441-445]

P. Tobias, S. Devaraj, I. Jialal, 2011 .

Demonstration of Increased TLR2 and TLR4 Expression in Monocytes of Type 1 Diabetic Patients with Microvascular Complications

S. Devaraj, I. Jialal, Jung-Mi Yun, 2011 .

LETTERS TO THE EDITORS

I. Jialal, I. K. Ashton, 1984 .

Detection of oligoclonal bands in cerebrospinal fluid by immunofixation electrophoresis.

I. Jialal, D. Cavuoti, L. Baskin, 1998, American journal of clinical pathology.

α-tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients

S. Devaraj, I. Jialal, A. Chan, 2002 .

Genetics, Epigenetic Mechanism

I. Jialal, Brittany N. Simpson, N. M. Aboud, 2020 .

Antilipemic Agent Bile Acid Sequestrants

I. Jialal, Daniella Lent-Schochet, 2019 .

Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers.

S. Devaraj, I. Jialal, Bryce C Autret, 2006, The American journal of clinical nutrition.

Effect of Aloe vera Supplements in Patients with Pre‐Diabetes

S. Devaraj, I. Jialal, Jason Rockwood, 2009 .

The effect of weight loss on a stable biomarker of inflammation, C-reactive protein.

I. Jialal, M. Dietrich, Marion Dietrich, 2005, Nutrition reviews.

What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?

I. Jialal, 2014, American journal of clinical pathology.

Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects.

Kit S Lam, Ruiwu Liu, Sridevi Devaraj, 2013, Metabolic syndrome and related disorders.

The cholesterol ester transfer protein inhibitor, anacetrapib.

I. Jialal, J. Kaur, 2011, Current opinion in lipidology.

Bence-Jones Protein

I. Jialal, N. Ramakrishnan, 2019 .

Folic Acid (Folate) Deficiency

I. Jialal, K. Khan, 2019 .

Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia.

S. Devaraj, I. Jialal, Bryce C Autret, 2006, The American journal of cardiology.

High-dosage vitamin E supplementation and all-cause mortality.

S. Devaraj, I. Jialal, 2005, Annals of internal medicine.

Fetuin-A is also an adipokine

I. Jialal, R. Pahwa, 2019, Lipids in Health and Disease.

Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results.

L. Beckett, I. Jialal, Yueju Li, 2007, American journal of clinical pathology.

Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.

I. Jialal, Dana Sheely, 2013, Metabolic syndrome and related disorders.

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

A. Remaley, I. Jialal, Rafael Zubirán, 2023, Journal of clinical medicine.

Nutritional Modulation of Inflammation in Metabolic Syndrome

U. Singh, S. Devaraj, I. Jialal, 2007 .

Pharmacotherapy for the metabolic syndrome.

I. Jialal, A. Swislocki, D. Siegel, 2012, Current vascular pharmacology.

Ratio of remnant-like particle cholesterol to serum total triglycerides is a reliable screening test for type III dyslipidaemia

S. Devaraj, I. Jialal, S. Hirany, 2000, Annals of clinical biochemistry.

Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.

S. Devaraj, I. Jialal, Basir Syed, 2012, American journal of clinical pathology.

Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

S. Grundy, B. Adams-Huet, S. Devaraj, 2001, Circulation.

C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production

J. Reusch, U. Singh, S. Devaraj, 2006, Arteriosclerosis, thrombosis, and vascular biology.

The evolving role of toll-like receptors in diabetic vascular complications.

I. Jialal, R. Pahwa, 2015, Journal of diabetes and its complications.

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome

B. Adams-Huet, S. Devaraj, I. Jialal, 2023, Journal of clinical medicine.

Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin.

S. Devaraj, I. Jialal, Jung-Mi Yun, 2011, The Journal of nutritional biochemistry.

Therapy and clinical trials: ezetimibe.

I. Jialal, T. Kappagoda, 2003, Current opinion in lipidology.

Editorial comment Therapy and clinical trials: ezetimibe

I. Jialal, T. Kappagoda, 2003 .

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.

S. Devaraj, I. Jialal, 2001, American journal of clinical pathology.

Therapy and clinical trials.

M. Chandalia, I. Jialal, Manisha Chandaliaa, 2005, Current opinion in lipidology.

A novel peptide inhibitor attenuates C-reactive protein's pro-inflammatory effects in-vivo.

G. Smith, S. Devaraj, I. Jialal, 2013, International journal of cardiology.

Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein.

I. Jialal, S. M. Grundy, 1992, Journal of lipid research.

Small Interfering-RNA to Protein Kinase C-Delta Reduces the Proinflammatory Effects of Human C-Reactive Protein in Biobreeding Diabetic Rats

I. Jialal, A. Machha, S. Devaraj, 2012, Hormone and Metabolic Research.

The Evolving Role of C-Reactive Protein in Heart Failure: Implications for Patients With Cardiovascular Disease.

I. Jialal, I. Ebong, 2023, Journal of the American College of Cardiology.

Biochemistry, Fat Soluble Vitamins

I. Jialal, P. Reddy, 2020 .

Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase.

S. Devaraj, I. Jialal, 2005, Free radical biology & medicine.

Dietary factors that promote or retard inflammation.

S. Devaraj, I. Jialal, A. Basu, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Low Vitamin D Levels in Northern American Adults with the Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

An Increasing Triglyceride–Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype

B. Adams-Huet, I. Jialal, 2024, Journal of clinical medicine.

Chemerin levels in metabolic syndrome: a promising biomarker

I. Jialal, 2021, Archives of physiology and biochemistry.

Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.

B. Adams-Huet, I. Jialal, D. Siegel, 2017, Journal of diabetes and its complications.

Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.

U. Singh, I. Jialal, B. Huet, 2010, Atherosclerosis.

Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study

I. Jialal, A. Swislocki, L. M. SwislockiArthur, 2016 .

Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome.

G. Fadini, S. Devaraj, I. Jialal, 2010, The American journal of cardiology.

Endothelial progenitor cell status in metabolic syndrome.

I. Jialal, 2010, Metabolic syndrome and related disorders.

ATVB In Focus Nutrition and Atherosclerosis

P. Kris-Etherton, S. Devaraj, I. Jialal, 2006 .

Increased neutrophil count in nascent metabolic syndrome.

B. Adams-Huet, I. Jialal, H. Kaur, 2013, Metabolic syndrome and related disorders.

Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease

P. Tam, I. Jialal, B. Nathoo, 2017, Nephron.

Biochemistry, Apolipoprotein B

S. Devaraj, I. Jialal, 2019 .